Asthma is a chronic airway disease characterized by reversible airflow limitation with airway wall thickening. Although some studies have reported changes in airway dimensions estimated on chest CT in patients with chronic asthma, little is known about dynamic changes in airway dimensions between acute exacerbations of asthma and recovery. Our case documents significant changes in the bronchial wall, as estimated on serial chest CT scans, over a short-term interval during an exacerbation of asthma.
Introduction
Chest computed tomography (CT) scanning allows for the assessment of airways in patients with various obstructive lung diseases. The airway dimensions estimated on CT scans are known to be positively correlated with the pulmonary function and a positive response to treatment (1) (2) (3) (4) . Asthma is characterized by variable airflow obstruction along with thickening of the airway walls. Airway remodeling is also a well-established feature of asthma. Most studies have reported only the structural features of chest CT airway estimates in patients with chronic asthma (4, 5) as it is difficult to obtain chest CT images in patients with acute exacerbations of asthma. Therefore, few studies have reported the dynamic changes in airway dimensions that occur between phases (i.e., acute exacerbation of asthma and recovery), as measured on chest CT scans. We were recently able to obtain serial chest CT scans between two phases of an asthma attack. We herein describe the changes in CT scan-estimated airway dimensions.
Case Report
A 70-year-old woman, diagnosed with bronchial asthma at 35 years of age, presented with severe dyspnea occurring two days previously. She was not a smoker, and her asthma had been kept stable with a short-acting β2-receptor agonist inhaler and an oral leukotriene-receptor antagonist. On physical examination, expiratory wheezing was heard in both lung fields. The patient's vital signs were as follows; blood pressure: 140/82 mmHg, pulse rate: 113 beats/min, respiratory rate: 30/min and body temperature: 37.8 .
Chest radiography revealed diffuse thickening of the bronchovascular bundles and hyperinflation in both lung zones. An arterial blood gas analysis performed on room air demonstrated hypoxia with a PaO2 of 51 mmHg, a PaCO2 of 37.3 mmHg, a pH 7.41 and a SaO2 of 86%. The patient's IgE level and serum eosinophil count were not significantly elevated. Under the assumption that she was experiencing an acute exacerbation of asthma complicated by a respiratory tract infection, systemic glucocorticoids were administered with oxygen supplementation. A short-acting β2-receptor agonist and glucocorticoids were also inhaled through a nebulizer. The dyspnea and cough continued in spite of the administration of treatment for four days. The delayed response to treatment prompted an attending physician to perform pulmonary function tests (PFTs) and chest CT (Brilliance 64, Philips Healthcare, Cleveland, OH, USA).
The PFT showed an FEV1/FVC of 0.45, a predicted FVC of 65% (absolute value: 1.62 liters), a predicted FEV1 of 38% (0.73 liters), a predicted diffuse capacity for carbon monoxide of 72% (12.6 mL/mmHg/min), a predicted total lung capacity of 108% (5.00 liters), a residual volume of 183% (3.39 liters), and a predicted inspiratory capacity of 52% (0.95 liters), which suggested the presence of severe obstructive pattern along with hyperinflation. Grossly, chest CT showed diffuse and severe bronchial wall thickening with luminal narrowing in both lungs (Fig. 1) . No consolidation or ground glass opacities were detected on chest CT.
After being hospitalized for ten days, the patient was treated with a long-acting β2-receptor agonist/glucocorticoid inhaler and low-dose systemic glucocorticoids at an outpatient clinic. During this period, she did not complain of any symptoms, including dyspnea, cough or sputum. She then presented with a fever without dyspnea two weeks after discharge. No wheezing was auscultated. A follow-up chest CT scan was performed to evaluate the cause of the fever. The bronchial wall thickness was decreased (Fig. 2) . A consolidation had developed in the right middle lobe (Fig. 2C) . Anti-pseudomonal β-lactam and respiratory fluoroquinolone were administered based on a diagnosis of newly developed bacterial pneumonia. The PFTs were not performed because the patient did not complain of dyspnea.
Using two-phase (exacerbation and recovery) CT scans, the airway dimensions were compared. The luminal area (LA) and airway wall area (WA), parameters used to assess airway narrowing and remodeling, were obtained using a commercial workstation (TeraRecon Aquarius). To obtain the most accurate measurements, CT images perpendicular to the long axis of the 3rd to 6th generation of bronchi were selected in an apical segment and the posterobasal segment of the right lung, and the apicoposterior and posterobasal segment of the left lung. Fig. 3 shows snapshots of the procedure. The percentages of LA (LA%) and WA (WA%) were calculated according to the methodology reported in a previous study (6) .
The WA% increased during asthma exacerbation regardless of the generation of bronchi, and the absolute values of WA also exhibited an increasing trend during exacerbation (Table 1 ). In contrast, the LA% decreased to the same extent during exacerbation, and the absolute values of LA exhibited a decreasing trend ( Table 2 ). The degree of differences in WA% and LA% between the two phases increased as the generation of bronchi increased (Tables 1, 2 ). Sixth generation bronchi in both upper lobes, which were seen during exacerbation, disappeared at the time of recovery. This means that there was a decrease in the WA.
Discussion
Bronchial asthma is a common airway disease characterized by reversible airflow limitation and airway hyperresponsiveness to constricting stimuli. Some asthmatics exhibit irreversible airflow limitations caused by airway remodeling despite the administration of treatment, as in chronic obstructive pulmonary disease (COPD) (7) .
CT scanning is a remarkable tool for assessing airway wall morphology in vivo and aids in the understanding of complex mechanisms underlying the so-called remodeling process. There are differences in airway inflammation between asthma and COPD in terms of physiology, pathology and biology. A recent study demonstrated that airway remodeling assessed by CT in patients with asthma is more asthma and recovery) show the process of manually measuring the airway dimension using the commercial workstation (TeraRecon Aquarius). After selecting a segmental bronchus, the author manually traced the inner and outer edges of the airway wall using the software program. After tracing the outer edge, the lumen area (LA) plus the wall area (WA) were measured. After tracing the inner edge, the LA was measured. prominent than that observed in age-and sex-matched COPD subjects in 3rd to 6th generation airways when airflow limitations are similar under stable clinical conditions (8) .
However, it is not certain which generation of bronchi is narrowed more prominently, how the bronochi are narrowed and whether the remodeled bronchi are also narrowed at the time of asthma exacerbation. Unfortunately, it is very difficult to design and conduct a study to answer these questions. First, severe dyspnea makes it difficult to obtain chest CT scans in patients with acute exacerbations of asthma. Second, the use of a short-term follow-up CT is not clinically needed after recovery from exacerbation. Third, exposure to radiation over a short interval is an ethical consideration. We were able to obtain serial chest CT scans within a short time period in a patient experiencing acute exacerbation of asthma. Although manual assessments may yield measurement bias, and the level of measurement on CT scans between two phases may not be completely the same, in our case, the differences in the absolute values and percentages of WA and LA between the two phases increased and decreased, respectively, as the generation of bronchi increased.
This indicates that the changes in airway walls that develop during exacerbation are more prominent in the more distal airways. It is also possible to speculate that the degree of airway reversibility increases as the generation of bronchi increases, which suggests that airway remodeling may be more prominent or starts earlier in the more proximal airways. This may have important clinical implications, in that particles of anti-inflammatory drugs delivered via inhaler must reach more distal airways in order to achieve better efficacy and prevent airway remodeling. However, this report concerns a single case. Therefore, more studies are needed to prove this speculation. It is important to describe the relationship between changes in airway dimension observed on CT scans and changes in the pulmonary function. However, it is unfortunate that we were not able to obtain the results of PFT during the recovery phase. Therefore, there is a possibility that the patient did not completely recover from the exacerbation. However, the patient did not complain of dyspnea or coughing until the second hospital visit. In addition, no wheezing was audible. The patient experienced no limitations of usual activities following discharge. We believe that follow-up chest CT scanning can reflect the features of the recovery stage, based on clinical improvement.
To the best of our knowledge, this is the first case report to assess changes in airway dimensions estimated on CT scans between two phases over a short interval. As mentioned above, as it is very difficult to obtain serial chest CT scans within the short time interval between exacerbation and recovery, we feel that our case offers insight into the mechanisms and/or phenomena of airway narrowing and/or remodeling during acute exacerbations of asthma.
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